Narcotic requirements after shoulder arthroplasty are low using a multimodal approach to pain

© 2021 The Authors.

Bibliographische Detailangaben
Veröffentlicht in:JSES international. - 2020. - 5(2021), 4 vom: 11. Juli, Seite 722-728
1. Verfasser: Sethi, Paul M (VerfasserIn)
Weitere Verfasser: Mandava, Nikhil K, Liddy, Nicole, Denard, Patrick J, Haidamous, Georges, Reimers, Charles D
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2021
Zugriff auf das übergeordnete Werk:JSES international
Schlagworte:Journal Article Arthroplasty Bupivacaine Liposomal Narcotic Opioids Reduction Shoulder Surgery
LEADER 01000naa a22002652 4500
001 NLM32770067X
003 DE-627
005 20231225201350.0
007 cr uuu---uuuuu
008 231225s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jseint.2021.02.005  |2 doi 
028 5 2 |a pubmed24n1092.xml 
035 |a (DE-627)NLM32770067X 
035 |a (NLM)34223421 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Sethi, Paul M  |e verfasserin  |4 aut 
245 1 0 |a Narcotic requirements after shoulder arthroplasty are low using a multimodal approach to pain 
264 1 |c 2021 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Revised 24.04.2022 
500 |a published: Electronic-eCollection 
500 |a Citation Status PubMed-not-MEDLINE 
520 |a © 2021 The Authors. 
520 |a BACKGROUND: Recent "multimodal" approaches to pain, although understudied, have shown promise in reducing reliance on narcotics in shoulder arthroplasty (SA). Many surgeons report being unsure of how many narcotic pills to prescribe after the surgery. As result, patients are prescribed upwards of 60 oxycodone 5-mg pills for a 6-to-12-week treatment period despite studies showing postoperative pain can be managed without any medication at all 
520 |a PURPOSE: The purpose of this multicenter study was to prospectively determine the number of opiate pills required after SA to develop generalizable, evidence-based prescription guidelines for surgeons. We hypothesized that opioid prescription would be low using a multimodal approach to pain management 
520 |a METHODS: The study enrolled 63 patients undergoing SA. Subjects received either an interscalene nerve block with liposomal bupivacaine, standard bupivacaine, or a local infiltration standard bupivacaine field block based on preference. All subjects were provided with postoperative "Pain Journals" to document their daily pain on a Numerical Rating Scale and daily opioid consumption during the 14-day postoperative period 
520 |a RESULTS: Overall, patients consumed an average of 8.6 oxycodone 5-mg pills (64.5 morphine milligram equivalents) after SA. Seventy-nine percent of patients required 15 or fewer oxycodone 5-mg pills, and 27% successfully managed their postoperative pain with zero opioids. Average pain remained low for patients in all groups 
520 |a CONCLUSION: With a multimodal approach, most patients undergoing SA can manage postoperative pain with 15 or fewer oxycodone 5-mg tablets, or 112.5 morphine milligram equivalents. The addition of a liposomal bupivacaine interscalene nerve block may further reduce the consumption of postoperative narcotics compared with a standard interscalene nerve block. This study provides evidence that may be used for surgeon guidelines in the effort to reduce opioid prescriptions after SA 
650 4 |a Journal Article 
650 4 |a Arthroplasty 
650 4 |a Bupivacaine 
650 4 |a Liposomal 
650 4 |a Narcotic 
650 4 |a Opioids 
650 4 |a Reduction 
650 4 |a Shoulder 
650 4 |a Surgery 
700 1 |a Mandava, Nikhil K  |e verfasserin  |4 aut 
700 1 |a Liddy, Nicole  |e verfasserin  |4 aut 
700 1 |a Denard, Patrick J  |e verfasserin  |4 aut 
700 1 |a Haidamous, Georges  |e verfasserin  |4 aut 
700 1 |a Reimers, Charles D  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t JSES international  |d 2020  |g 5(2021), 4 vom: 11. Juli, Seite 722-728  |w (DE-627)NLM307818438  |x 2666-6383  |7 nnns 
773 1 8 |g volume:5  |g year:2021  |g number:4  |g day:11  |g month:07  |g pages:722-728 
856 4 0 |u http://dx.doi.org/10.1016/j.jseint.2021.02.005  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_50 
912 |a GBV_ILN_65 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 5  |j 2021  |e 4  |b 11  |c 07  |h 722-728